These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 2880951)
1. MDMA and human sexual function. Buffum J; Moser C J Psychoactive Drugs; 1986; 18(4):355-9. PubMed ID: 2880951 [No Abstract] [Full Text] [Related]
2. Ecstacy: a review of MDMA and MDA. Climko RP; Roehrich H; Sweeney DR; Al-Razi J Int J Psychiatry Med; 1986-1987; 16(4):359-72. PubMed ID: 2881902 [TBL] [Abstract][Full Text] [Related]
3. The background and chemistry of MDMA. Shulgin AT J Psychoactive Drugs; 1986; 18(4):291-304. PubMed ID: 2880943 [No Abstract] [Full Text] [Related]
4. Information on "Ecstasy". Greer G; Strassman RJ Am J Psychiatry; 1985 Nov; 142(11):1391. PubMed ID: 2865906 [No Abstract] [Full Text] [Related]
5. MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conference. May 17-18, 1986, Oakland, California. J Psychoactive Drugs; 1986; 18(4):287-379. PubMed ID: 2880942 [No Abstract] [Full Text] [Related]
6. Subjective reports of the effects of MDMA in a clinical setting. Greer G; Tolbert R J Psychoactive Drugs; 1986; 18(4):319-27. PubMed ID: 2880946 [No Abstract] [Full Text] [Related]
7. Meetings at the edge with Adam: a man for all seasons? Wolfson PE J Psychoactive Drugs; 1986; 18(4):329-33. PubMed ID: 2880947 [No Abstract] [Full Text] [Related]
8. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. Nichols DE J Psychoactive Drugs; 1986; 18(4):305-13. PubMed ID: 2880944 [No Abstract] [Full Text] [Related]
10. Designer drug confusion: a focus on MDMA. Beck J; Morgan PA J Drug Educ; 1986; 16(3):287-302. PubMed ID: 2877058 [No Abstract] [Full Text] [Related]
11. Some observations on MDMA experiences induced through posthypnotic suggestion. Hastings A J Psychoactive Drugs; 1994; 26(1):77-83. PubMed ID: 7913132 [No Abstract] [Full Text] [Related]
12. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine. Lorens SA; Hata N; Cabrera T; Hamilton ME NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039 [No Abstract] [Full Text] [Related]
13. Behavioral suppression following 3,4-methylenenedioxymethamphetamine. Kulmala HK; Boja JW; Schechter MD Life Sci; 1987 Sep; 41(11):1425-9. PubMed ID: 2887995 [TBL] [Abstract][Full Text] [Related]
14. The scheduling of MDMA: a pharmacist's perspective. Riedlinger JE J Psychoactive Drugs; 1985; 17(3):167-71. PubMed ID: 2865343 [No Abstract] [Full Text] [Related]
16. The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats. Hiramatsu M; Nabeshima T; Kameyama T; Maeda Y; Cho AK Pharmacol Biochem Behav; 1989 Jun; 33(2):343-7. PubMed ID: 2573077 [TBL] [Abstract][Full Text] [Related]
17. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Beardsley PM; Balster RL; Harris LS Drug Alcohol Depend; 1986 Oct; 18(2):149-57. PubMed ID: 2877842 [TBL] [Abstract][Full Text] [Related]
18. The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice. Glennon RA; Little PJ; Rosecrans JA; Yousif M Pharmacol Biochem Behav; 1987 Feb; 26(2):425-6. PubMed ID: 2883666 [TBL] [Abstract][Full Text] [Related]